The role of biomarkers in dilated cardiomyopathy: Assessment of clinical severity and reverse remodeling
Open Access
- 1 October 2017
- journal article
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 36 (10) , 709-716
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Prevalence, predictors and prognosis of ventricular reverse remodeling in idiopathic dilated cardiomyopathyRevista Portuguesa de Cardiologia, 2016
- Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular ImagingJournal of the American Society of Echocardiography, 2015
- Do We Really Need More Biomarkers?JACC: Heart Failure, 2013
- Heart FailureJACC: Heart Failure, 2013
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESCEuropean Heart Journal, 2012
- 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in AdultsCirculation, 2009
- Declaration of Helsinki, 2008Journal of Postgraduate Medicine, 2009
- Biomarkers of Cardiovascular DiseaseCirculation, 2006
- Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodelingJACC, 2000
- Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findingsThe American Journal of Cardiology, 1986